WikiMD is a free medical encyclopedia moderated by medical professionals and is a reliable source of information on a wide range of health, weight loss and wellness related topics. Who wants to trust their health with amateurs?
|Classification and external resources|
Crigler–Najjar syndrome or CNS is a rare disorder affecting the metabolism of bilirubin, a chemical formed from the breakdown of red blood cells. The disorder results in an inherited form of non-hemolytic jaundice, which results in high levels of unconjugated bilirubin and often leads to brain damage in infants.
This syndrome is divided into type I and type II, with the latter sometimes called Arias syndrome. These two types, along with Gilbert's syndrome, Dubin–Johnson syndrome, and Rotor syndrome, make up the five known hereditary defects in bilirubin metabolism. Unlike Gilbert's syndrome, only a few hundred cases of CNS are known.
This is a very rare disease (estimated at 0.6–1.0 per million live births), and consanguinity increases the risk of this condition (other rare diseases may be present). Inheritance is autosomal recessive.
Intense jaundice appears in the first days of life and persists thereafter. Type 1 is characterised by a serum bilirubin usually above 345 µmol/L (310–755) (whereas the reference range for total bilirubin is 2–14 μmol/L).
No UGT1A1 (UDP glucuronosyltransferase 1 family, polypeptide A1) expression can be detected in the hepatic tissue. Hence, there is no response to treatment with phenobarbital (which causes CYP450 enzyme induction). Most patients (type IA) have a mutation in one of the common exons (2 to 5), and have difficulties conjugating several additional substrates (several drugs and xenobiotics). A smaller percentage of patients (type IB) have mutations limited to the bilirubin-specific A1 exon; their conjugation defect is mostly restricted to bilirubin itself.
- exchange transfusions in the immediate neonatal period
- 12h/d phototherapy
- heme oxygenase inhibitors to reduce transient worsening of hyperbilirubinemia (although the effect decreases over time)
- oral calcium phosphate and carbonate to form complexes with bilirubin in the gut,
- liver transplantation before the onset of brain damage and before phototherapy becomes ineffective at later age
Type II differs from type I in several aspects:
- Bilirubin levels are generally below 345 µmol/L (100–430; thus, there is overlap), and some cases are only detected later in life.
- Because of lower serum bilirubin, kernicterus is rare in type II.
- Bile is pigmented, instead of pale in type I or dark as normal, and monoconjugates constitute the largest fraction of bile conjugates.
- UGT1A1 is present at reduced but detectable levels (typically <10% of normal), because of single base pair mutations.
- Therefore, treatment with phenobarbital is effective, generally with a decrease of at least 25% in serum bilirubin. In fact, this can be used, along with these other factors, to differentiate type I and II.
- The inheritance pattern of Crigler–Najjar syndrome type II has been difficult to determine but is generally considered to be autosomal recessive.
Hyperbilirubinemia of the unconjugated type may be caused by
- increased production
- decreased clearance
In Crigler–Najjar syndrome and Gilbert syndrome, routine liver function tests are normal, and hepatic histology usually is, too. There is no evidence for hemolysis. Drug-induced case typically regress after discontinuation of the substance. Physiological neonatal jaundice may peak at 85–170 µmol/L and decline to normal adult concentrations within two weeks. Prematurity results in higher levels.
The homozygous Gunn rat, which lacks the enzyme uridine diphosphate glucuronyltransferase (UDPGT), is an animal model for the study of Crigler–Najjar syndrome. Since there is only one enzyme working improperly, gene therapy for Crigler Najjar is a theoretical option which is being investigated.
Gunn Rat: Dr. C. H. Gunn discovered a mutant rat in 1934 at the Connaught Laboratory in Toronto, Canada. These rats were jaundiced and the defect was transmitted as an autosomal recessive characteristic. Dr Gunn, a Geneticist, bred them at Connaught and later moved to Summerside, Prince Edward Island, Canada to head up the Canadian Experimental Fox Ranch. Gunn rats are still commercially available today from Harlan, Indianapolis, Indiana. Gunn rats are also available from Japan SLC Inc.. This animal model has been extremely valuable for the development of experimental treatments for this disease.
- Chowdhury, J. R.; Wolkoff, A. W.; Chowdhury, N. R.; Arias, I. M.: "Hereditary jaundice and disorders of bilirubin metabolism." In: Scriver, C. R.; Beaudet, A. L.; Sly, W. S.; Valle, D. (eds.): The Metabolic and Molecular Bases of Inherited Disease. Vol. 2. New York: McGraw-Hill (8th ed.) 2001. Pp. 3063–3101.
- synd/86 at Who Named It?
- Info and links related to Crigler–Najjar
- Crigler–Najjar syndrome, type 1 at NIH's Office of Rare Diseases
- Crigler–Najjar syndrome, type 2 at NIH's Office of Rare Diseases
Table of contents:
# - A
- Adrenal gland disorders
- AIDS / HIV
- ADHD or Attention deficit/hyperactivity disorder
- Autism spectrum disorder (ASD)
- Bacterial vaginosis
- Birth control (see contraception)
- Birth defects
- Breastfeeding and breast milk
- Brittle bone disease also called osteogenesis imperfecta
- Cerebral palsy
- Childbirth see labor and delivery
- Childhood cancers
- Children's bone health and calcium
- Congenital adrenal hyperplasia (cah)
- Contraception and birth control
- Cushing syndrome
- Cyberbullying see bullying
- Delayed puberty see puberty and precocious puberty)
- Dental health in children
- Down syndrome
- Driving risk
Table of contents:
- Ear infections in children
- Early labor and birth (see preterm labor and birth)
- Early learning
- Early puberty (see puberty and precocious puberty)
- Eczema and atopic dermatitis
- Fertility problems (see infertility and fertility)
- Fibroids (see uterine fibroids)
- Fragile x syndrome
- Fragile x-associated primary ovarian insufficiency (fxpoi)
- Fragile x-associated tremor and ataxia syndrome (fxtas)
- Hellp syndrome (see preeclampsia and eclampsia)
- High-risk pregnancy
- HIV and AIDS]]
- Infant care and infant health
- Infant mortality
- Infertility and fertility
- Intellectual and developmental disabilities
Table of contents:
- Maternal mortality
- Mccune-albright syndrome (mas)
- Men's reproductive health
- Menkes disease
- Menstruation and menstrual problems
- Miscarriage (see pregnancy loss (before 20 weeks of pregnancy))
- Monosomy x (see turner syndrome)
- Muscular dystrophy
Table of contents:
- Pediatric injury
- Pelvic floor disorders
- Pelvic pain
- Pheochromocytoma and paraganglioma
- Pituitary tumors
- Polycystic ovary syndrome
- Prader-willi syndrome
- Preconception care and prenatal care
- Preeclampsia and eclampsia
- Pregnancy loss (before 20 weeks of pregnancy)
- Preterm labor and birth
- Primary ovarian insufficiency
- Puberty and precocious puberty
- Reading and reading disorders
- Rehabilitation medicine
- Rehabilitative and assistive technology
- Rett syndrome
- Rh incompatibility
- Sexually transmitted diseases
- Shaken baby syndrome
- Skipped or no menstrual periods (see amenorrhea
- Spina bifida
- Spinal cord injury
- Spinal muscular atrophy
- Sudden infant death syndrome
- Toxemia (see preeclampsia and eclampsia)
- Traumatic brain injury
- Trisomy 21 (see down syndrome)
- Turner syndrome
Table of contents:
Glossaries and dictionaries | Medicine portal | Health Topics | Health Encyclopedia | First Aid | Weight Loss | Drugs | Glossary of medicine | insurance | Glossary of health topics | Drug classes | Medicines | Dentistry portal | Medications portal | Pharmacology portal | Psychiatry portal | Rare diseases | List of health topics | USMLE